Lundbeck International Trademark (WIPO) Information
Pharmaceuticals and medical preparations and substances;
vaccines; pharmaceutical preparations and substances for the
prevention and treatment of disorders and diseases in
generated by or acting on the central nervous system;
pharmaceutical preparations and substances acting on the
central nervous system; central nervous system stimulants;
pharmaceutical preparations and substances for the
prevention and treatment of psychiatric and neurological
disorders and diseases; pharmaceutical preparations and
substances for the prevention and treatment of dementia,
Alzheimer's disorder and disease, dizziness, seizures,
stroke, depression, cognitive impairment, cognitive
disorders and diseases, mood disorders, psychosis, anxiety,
apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis,
porphyria, Huntington's disorder and disease, insomnia,
Parkinson's disorder and disease, falls, movement disorders
and diseases, dyskinesia, poor or absent motor functions,
tremor, schizophrenia, bipolar disorder and disease, mania,
ADHD, PTSD, agitation, aggression, autism, melancholy, OCD,
Tourette's syndrome, progressive supranuclear palsy (PSP),
restlessness, akathisia, fatigue,...
Perfect for these industries
Words that describe this mark
pharmaceuticals medical preparations substances vaccines pharmaceutical preparations substances prevention treatment disorders diseases generated acting central nervous pharmaceutical preparations substances acting central nervous central nervous stimulants pharmaceutical preparations substances prevention treatment psychiatric neurological disorders diseases pharmaceutical preparations substances
On Wednesday, June 19, 2019, an International Trademark registration was filed for
Lundbeck by H. Lundbeck A/S *********, **********, ***** ****.
The World Intellectual Property Organization (WIPO) has given the trademark application number of
1484324.
The expiration date for this trademark is 6/19/2029.
The Lundbeck
trademark is filed in the description of
Pharmaceuticals and medical preparations and substances;
vaccines; pharmaceutical preparations and substances for the
prevention and treatment of disorders and diseases in
generated by or acting on the central nervous system;
pharmaceutical preparations and substances acting on the
central nervous system; central nervous system stimulants;
pharmaceutical preparations and substances for the
prevention and treatment of psychiatric and neurological
disorders and diseases; pharmaceutical preparations and
substances for the prevention and treatment of dementia,
Alzheimer's disorder and disease, dizziness, seizures,
stroke, depression, cognitive impairment, cognitive
disorders and diseases, mood disorders, psychosis, anxiety,
apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis,
porphyria, Huntington's disorder and disease, insomnia,
Parkinson's disorder and disease, falls, movement disorders
and diseases, dyskinesia, poor or absent motor functions,
tremor, schizophrenia, bipolar disorder and disease, mania,
ADHD, PTSD, agitation, aggression, autism, melancholy, OCD,
Tourette's syndrome, progressive supranuclear palsy (PSP),
restlessness, akathisia, fatigue, somnolence, nausea,
cancer, migraine, pain, alcoholism and dependency;
preparations, substances, reagents and agents for diagnostic
and medical purposes.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
| Class Code: |
005 - Pharmaceutical Products
|
| Class Description: |
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
|
| Goods & Services: |
Pharmaceuticals and medical preparations and substances;
vaccines; pharmaceutical preparations and substances for the
prevention and treatment of disorders and diseases in
generated by or acting on the central nervous system;
pharmaceutical preparations and substances acting on the
central nervous system; central nervous system stimulants;
pharmaceutical preparations and substances for the
prevention and treatment of psychiatric and neurological
disorders and diseases; pharmaceutical preparations and
substances for the prevention and treatment of dementia,
Alzheimer's disorder and disease, dizziness, seizures,
stroke, depression, cognitive impairment, cognitive
disorders and diseases, mood disorders, psychosis, anxiety,
apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis,
porphyria, Huntington's disorder and disease, insomnia,
Parkinson's disorder and disease, falls, movement disorders
and diseases, dyskinesia, poor or absent motor functions,
tremor, schizophrenia, bipolar disorder and disease, mania,
ADHD, PTSD, agitation, aggression, autism, melancholy, OCD,
Tourette's syndrome, progressive supranuclear palsy (PSP),
restlessness, akathisia, fatigue, somnolence, nausea,
cancer, migraine, pain, alcoholism and dependency;
preparations, substances, reagents and agents for diagnostic
and medical purposes. |